Lupus (Systemic Lupus Erythematosus)
Systemic lupus erythematosus (SLE or lupus) is a chronic autoimmune disease in which the immune system attacks the body's own tissues and organs. Lupus can affect many body systems including joints, skin, kidneys, blood cells, brain, heart, and lungs. The disease is characterized by periods of flares and remission.
Prevalence
Lupus affects approximately 1.5 million Americans and 5 million people worldwide. About 16,000 new cases are diagnosed each year in the US.
Who It Affects
Women are affected 9 times more often than men. Lupus is more common and often more severe in African Americans, Hispanics, and Asian Americans. It typically develops between ages 15-45.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Antimalarial Drugs
Hydroxychloroquine helps control lupus symptoms and prevent flares.
Limitations: Requires eye monitoring for rare retinal toxicity. May not be sufficient alone for severe lupus.
Corticosteroids
Prednisone and other steroids to quickly control inflammation during flares.
Limitations: Significant long-term side effects (bone loss, diabetes, weight gain). Goal is to minimize use.
Immunosuppressants
Medications like mycophenolate, azathioprine, or cyclophosphamide to suppress overactive immune system.
Limitations: Increases infection risk. Requires close monitoring. Some patients don't tolerate or don't respond.
Biologics
Targeted therapies like belimumab or anifrolumab for moderate to severe lupus.
Limitations: Expensive. Not effective for all patients. Increased infection risk.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for lupus is an emerging area of research exploring whether biologics with immunomodulatory properties may help modulate the overactive immune response. Some stem cell approaches, including autologous hematopoietic stem cell transplant, have been studied for severe, refractory lupus.
Potential Benefits Being Studied:
- Being studied for potential immunomodulatory effects
- May help modulate autoimmune response (under investigation)
- HSCT studied in severe, refractory cases
- MSCs being researched for anti-inflammatory properties
- An area of active clinical research
- Does not replace standard lupus management
Biologics Used:
Mesenchymal stem cells in clinical research
Hematopoietic stem cell transplant (severe cases only)
Frequently Asked Questions
Can stem cells cure lupus?
There is no cure for lupus. Autologous stem cell transplant has shown promise in some severe, treatment-resistant cases, but it is an intensive procedure with significant risks. Other regenerative approaches remain experimental.
Should I stop my lupus medications?
Never stop lupus medications without your rheumatologist's guidance. Uncontrolled lupus can cause serious organ damage. Any experimental therapy would be in addition to, not instead of, standard care.
Is this appropriate for lupus nephritis?
Lupus nephritis (kidney involvement) is serious and requires aggressive standard treatment. Research on regenerative therapies for lupus nephritis is very preliminary. Work closely with your nephrologist and rheumatologist.
Ready to Explore Your Options?
Schedule a free consultation to discuss lupus (systemic lupus erythematosus) and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for lupus are highly investigational and not FDA-approved. Lupus requires ongoing management by a rheumatologist. Never discontinue prescribed medications. Results vary significantly.